Fundraising Fox

Gilla Kaplan

Investor

Board Member at Avalo Therapeutics

Canada

About

Recognized authority on host immune response to mycobacterial pathogens including agents causing leprosy and tuberculosis. Previously Director of Global Health Tuberculosis program at Bill & Melinda Gates Foundation (2014–2018). Spent 20 years at Rockefeller University and 10 years at Public Health Research Institute Center leading immunology research and receiving multiple NIH-NIAID grants.

Experience

  1. Avalo, IncMember Board of Directorscurrent2020 — present
  2. Medicines Development for Global HealthSenior Advisercurrent2020 — present
  3. FreelanceSenior adviser in global health: tuberculosis amd leprosycurrent2018 — presentNew York, United States
  4. Heiser FoundationChair of Scientific Advisory Comiitteecurrent2016 — present
  5. Tyra BiosciencesMember Board of Directors2019 — 2026
  6. BMGFDirector, Global Health Tuberculosis Bill and Melinda Gates Foundation2013 — 2018Seattle, Washington, United States

Skills & more

CDD VAULT - Complexity Simplified

From Gilla's professional profile.

Colleagues at Avalo Therapeutics

Frequently asked questions

Who is Gilla Kaplan?
Recognized authority on host immune response to mycobacterial pathogens including agents causing leprosy and tuberculosis. Previously Director of Global Health Tuberculosis program at Bill & Melinda Gates Foundation (2014–2018). Spent 20 years at Rockefeller University and 10 years at Public Health Research Institute Center leading immunology research and receiving multiple NIH-NIAID grants.
Where does Gilla Kaplan work?
Gilla Kaplan is Board Member at Avalo Therapeutics.
Where did Gilla Kaplan go to school?
Gilla Kaplan studied at University of Tromso (Doctor of Philosophy - PhD, Cellular Immunology).

Shared employers